tirzepatide for weight loss philadelphia Specialist Near Me in Langhorne, and Philadelphia, PA Miami Tirzepatide Injections For Weight

Jessie DPC Member who inspired the Body Program, after taking GLP-1 medication Alex DPC Member after taking GLP-1 medication Introducing Tirzepatide, the game-changing active pharmaceutical ingredient driving the success of Mounjaro and Zepbound*, empowering thousands to achieve and sustain weight loss through diligent diet and exercise

After 72 weeks, the tirzepatide group Lost an additional 21.1% of their weight, while the placebo group regained 3.3% Lost 26.6% of their weight total, including the 12-week lifestyle intervention Had far more users with 5% weight loss than the placebo group (94.4% vs

All three responses are normal at this stage

Oral Wegovy (semaglutide 25 mg): the first approved oral GLP-1 for weight loss On December 22, 2025, the FDA approved oral Wegovy, making it the first and only oral GLP-1 medication approved specifically for weight management in adults

Pivotal phase 3 trials will begin this year

Learn more about potential side effects Your Ro-affiliated provider will walk you through the side effects patients report most often: Nausea Vomiting Upset stomach Stomach pains Constipation Diarrhea Learn more about safety information, including serious warnings: ro.co/safety/ Your timeline to treatment From personalized treatment to insurance support, we help you getand stayon track